永齡學者

腫瘤醫學研究所 蘇聖芳 專案助理教授

獲獎年度:2020-2021

研究專長:Cancer Epigenetics, Tumor Biology, Molecular and Cellular Biology.

近5年論文 Recent Publications

1.

Tseng CC, Jia B, Barndt R, Gu Y, Chen CY, Tseng IC, Su SF, Wang JK, Johnson MD, Lin CY. Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity. PLOS ONE. 2017 Aug 22; 12(8):e0183507. 
 

2.

Chao CT, Liu YP, Su SF, Yeh HY, Chen HY, Lee PJ, Chen WJ, Lee YM, Huang JW, Chiang CK, Hung KY, Chen HW. Circulating MicroRNA-125b Predicts the Presence and Progression of Uremic Vascular Calcification. ARTERIOSCLEROSIS THROMBOSIS and VASCULAR BIOLOGY. 2017 Jul; 37(7):1402-1414. 
 

3.

Su SF, de Castro Abreu AL, Chihara Y, Tsai Y, Andreu-Vieyra C, Daneshmand S, Skinner EC, Jones PA, Siegmund KD, Liang G. A panel of three markers hyper and hypomethylated in urine sediments accurately predicts bladder cancer recurrence. CLINICAL CANCER RESEARCH. 2014 Apr 1;20(7):1978-89.

(First author) 

4.

Lay FD, Triche TJ, Tsai YC, Su SF, Martin SE, Daneshmand S, Skinner EC, Liang G, Chihara Y, Jones PA. Reprogramming of the intestinal epigenome by surgical tissue transposition. GENOME RESEARCH. 2014 Apr;24(4):545-53. 

5.

Su SF, Chang YW, Andreu-Vieyra C, Fang JY, Yang Z, Han B, Lee AS, Liang G. miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. ONCOGENE. 2013 Sep 26;32(39):4694-701.

(First author) 

6.

De Carvalho DD, Sharma S, You JS, Su SF, Taberlay PC, Kelly TK, Yang X, Liang G, Jones PA. DNA methylation screening identifies driver epigenetic events of cancer cell survival. CANCER CELL. 2012 May 15;21(5):655-67.